ZURAMPIC (lesinurad)

SELF ADMINISTRATION

FDA Approved Indication:
  • Indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone
Prior authorization criteria:
  • Diagnosis of hyperuricemia associated with gout, AND
  • Despite trying and failing first-line agents, patient still has symptomatic hyperuricemia, AND
  • Will be used as combination therapy with a xanthine oxidase inhibitor (i.e., allopurinol or Uloric [febuxostat]), AND
  • Patient does not have any of the following: severe renal impairment (eCLcr < 45 mL/min), end stage renal disease, is a recipient of a kidney transplant, is on dialysis, or has severe (Child-Pugh class C) hepatic impairment, AND
  • Contraindicated for use in tumor lysis syndrome or Lesch-Nyhan syndrome where the rate of uric acid formation is greatly increased
Dosing:
  • 200 mg once daily in combination a xanthine oxidase inhibitor
Approval:
  • 1 year
Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone